Jump to ContentJump to Main Navigation
Knowledge as PropertyIssues in the Moral Grounding of Intellectual Property Rights$
Users without a subscription are not able to see the full content.

Rajshree Chandra

Print publication date: 2010

Print ISBN-13: 9780198065579

Published to Oxford Scholarship Online: October 2012

DOI: 10.1093/acprof:oso/9780198065579.001.0001

Show Summary Details
Page of

PRINTED FROM OXFORD SCHOLARSHIP ONLINE (oxford.universitypressscholarship.com). (c) Copyright Oxford University Press, 2020. All Rights Reserved. An individual user may print out a PDF of a single chapter of a monograph in OSO for personal use. date: 03 August 2020

Intellectual Property Rights and the Right to Health

Intellectual Property Rights and the Right to Health

The Glivec Patent Claim in India

(p.185) 6 Intellectual Property Rights and the Right to Health
Knowledge as Property

Rajshree Chandra

Oxford University Press

This chapter examines intellectual property rights in the context of the right to health. It presents the Novartis patent claim for the anti-cancer drug ‘Glivec’ in India as a case-study to highlight the infringement of health rights in the context of the high prices of patented drugs, which make vital drugs inaccessible to a vast majority of people, particularly poor people. The case brings to the fore issues of drug patenting, survival of generic drugs, and their impact on access to medicines, which are vital to the preservation of the right to health, an aspect of human rights, as well as a constitutional rights in many countries.

Keywords:   patent claims, Novartis, Glivec, health rights, drug patents, generic drugs

Oxford Scholarship Online requires a subscription or purchase to access the full text of books within the service. Public users can however freely search the site and view the abstracts and keywords for each book and chapter.

Please, subscribe or login to access full text content.

If you think you should have access to this title, please contact your librarian.

To troubleshoot, please check our FAQs , and if you can't find the answer there, please contact us .